Showing 1 posts of 1 posts found.
Novartis has announced internal structural changes that it says will “focus” its pharmaceuticals division by creating two business units, Novartis …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO